Sort   by:  
 Page size 
UnknownElucidation of structure-function relationships in Methanocaldococcus jannaschii RNase P, a multi-subunit catalytic ribonucleoprotein.
Not available
S-EPMC9371926 | biostudies-literature
UnknownA Scoping Review of Population Diversity in the Common Genomic Aberrations of Clear Cell Renal Cell Carcinoma.
Not available
S-EPMC11890214 | biostudies-literature
UnknownOncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis.
Not available
S-EPMC11474859 | biostudies-literature
UnknownCooperation between PRMT1 and PRMT6 drives lung cancer health disparities among Black/African American men.
Not available
S-EPMC10830871 | biostudies-literature
UnknownA Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.
Not available
S-EPMC7056559 | biostudies-literature
Unknown<i>HER2</i> Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.
Not available
S-EPMC11240881 | biostudies-literature
UnknownMethyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli.
Not available
S-EPMC4407145 | biostudies-literature
UnknownA Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma.
Not available
S-EPMC7725004 | biostudies-literature
UnknownPTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance.
Not available
S-EPMC4417419 | biostudies-literature
UnknownBlinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
Not available
S-EPMC8937010 | biostudies-literature
Sort   by:  
 Page size